Allergy Partners, Chief Executive Officer and Board-Certified Allergist, Bill McCann, MD, presented at the American College of Allergy, Asthma & Immunology 2025 Annual Scientific Meeting in Orlando, FL last week. Dr. McCann provided an overview of patient characteristics from a new retrospective study, MT RANIER. The goal of the study is to evaluate whether guidelines-based education, and/or electronic medical records alerts can improve asthma management when caring for patients with uncontrolled asthma in community practices.
Dr. Bill McCann presents MT RANIER study at ACAAI 2025
This title was summarized by AI from the post below.
More Relevant Posts
-
Dr. Lawrence Sher, Associate Medical Director at Peninsula Research Associates, a Headlands Research site, co-authored a phase 3 study evaluating the long-term safety of epicutaneous immunotherapy (EPIT) with the VIASKIN peanut patch in children with peanut allergy. The findings were published in The Journal of Allergy and Clinical Immunology. Results from the open-label extension of the REALISE trial showed that EPIT was well tolerated over 36 months, with high treatment adherence and decreasing frequency and severity of skin reactions over time. Read more: https://lnkd.in/eHGqU_vb #PeanutAllergy #Immunotherapy #ClinicalTrials #HeadlandsResearch
-
-
How do we strengthen allergy care from the ground up? In this new Patient Advocacy Voices video, Todd Mahr, Executive Medical Director of the American College of Allergy, Asthma and Immunology (ACAAI), joins Sanofi's Piya Sircar, to share how ACAAI is driving impact in patient care through education, collaboration, and community support. They discussed the importance of: 🔷Equipping healthcare providers with the tools they need to care for patients 🔷Empowering patients with accessible, reliable information 🔷Partnering across sectors to improve outcomes for allergy and immunology patients 🎥 Watch the full conversation here: https://lnkd.in/e_ASZppu #PatientAdvocacy #PatientEngagement #PatientAdvocacyVoices #HealthcareLeadership
-
More than 1,000 adults with eczema and caregivers shared what matters most when choosing treatments, and most said their doctor was the top influence. These findings underscore the importance of shared decision-making between patients and healthcare providers in eczema care. NEA is bringing new, data-driven eczema research — along with insights from our EczemaWise app — to the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting. We look forward to engaging with allergists, immunologists and healthcare professionals to share clinical resources, discuss our latest national survey findings and explore how this data can inform and improve patient care and outcomes in atopic dermatitis. #Eczema #AllergyCare #ImmunologyCare #ACAAI #GetEczemaWise #ACAAI25
-
-
#HAE News: Intellia presents positive follow-up data from its ongoing Phase 1/2 trial in #hereditaryangioedema at the American College of Allergy, Asthma and Immunology (ACAAI) Scientific Meeting. Read the press release: https://lnkd.in/eHkCjZWq
-
📖 What does it take to successfully launch a new open-access journal? In this week’s ORIGINal Thoughts, Justin Byrne, Executive Managing Editor at the American Academy of Allergy, Asthma & Immunology, shares his perspective on the process behind launching an open-access allergy journal. He explores the strategic decisions, collaboration, and long-term vision required to create a journal that expands access while maintaining quality and impact. Read the full post now: https://lnkd.in/dwgPHrP3 #oaweek #OpenAccess #ScholarlyPublishing #AcademicJournals #AllergyImmunology #OriginalThoughts
-
-
Discover our latest interactive article in EMJ Allergy & Immunology: “Global Perspectives on Challenges and Opportunities in Managing Allergic Rhinitis in Children: Taking the School Environment as a Case.” This expert-led piece explores how school environments can influence the development and management of allergic rhinitis in children, highlighting global challenges, practical strategies for creating allergy-friendly schools, and the importance of collaborative care. Read the full interactive article here: https://hubs.la/Q03RwKFf0 The publication of this article was funded by Bayer
-
How do #actinopathies lead to allergies and immune system imbalance? In a recent review published in the Journal of Allergy and Clinical Immunology, fellow Dr. Candice Gard and Dr. George Freigeh discuss these disorders, their allergic manifestations, treatments, and how providers can differentiate them from general atopy. Read the full article:
-
Why do doctors choose allergy and immunology? For many, it’s about finding a specialty that allows them to make a difference and still have time for the moments that matter most. In our latest video, we asked CIIC member Dr. Maaz Mohiuddin what inspired his path into allergy and immunology, and his answer sheds light on why balance matters in medicine. 🎥 Watch now to hear how work-life balance plays a defining role in his journey.
-
It was inspiring to see the future of immunology and allergy unfold at #ACAAI25! Last weekend at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Meeting, we shared new data on our treatment for chronic spontaneous urticaria (CSU). I was so proud to hear the feedback from medical experts and HCPs on the strong uptake and impact of our new CSU treatment in practice. Another highlight for me was meeting with the Asthma and Allergy Foundation of America to reinforce our shared commitment to the chronic hives community. Autoimmune diseases are complex and often misunderstood. That’s why we listen to patients and collaborate with researchers, clinicians, and advocates, ensuring our innovation reflects real-world needs. By combining groundbreaking science with deep expertise, we’re redefining standards of care and opening new possibilities for patients with limited options. Together, we’re building on a common purpose: addressing unmet needs and helping people with autoimmune diseases reclaim their lives. Discover more about our leadership in immunology: https://lnkd.in/emff8zHy
-
-
Allergy Testing in Malaysia – Is the Current Landscape Sufficient? On November 1, 2025, experts came together to discuss regulatory expectations, emerging technologies like NOVEOS®, and how precision-driven allergy diagnostics are shaping the future of patient care in Malaysia. This seminar brought together leading voices from Malaysia’s allergy and immunology community to explore key challenges, opportunities, and advancements — from pediatric drug allergy to tailored testing approaches that better guide immunotherapy. 📩 Interested in the full seminar materials? Connect with Bella zhao, Wei Wang or Eric Whitters PhD. to learn more. #AllergyDiagnostics #NOVEOS #ClinicalImmunology #ClinicalLaboratory #InVitroDiagnostics #immunotherapy #AllergyTesting #Malaysia #DiagnosticSolutions #AllergyAwareness #ImmunologyResearch
Dr. McCann That sounds like a great presentation! Your study is important because it looks at improving asthma management in community practices using guidelines-based education. Focusing on better care for patients with uncontrolled asthma is key in Allergy, Asthma & Immunology. Side Note: How does free credentialing, contracting and initial consultation sound? Yes, you read that right. Most providers are stuck with a slow, expensive submission process. At Veracity, we provide demonstrably better, faster, and cheaper payer submissions. We we'd love the opportunity to complete one free submission to prove our impact. We cover your needs, big or small! Let us show you the difference that guaranteed quality makes. We look forward to connecting with you! Phone: 812-604-5870 Email: office@veracityeg.com Web: veracityeg.com